| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,386 |
2,842 |
$151K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
602 |
538 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
230 |
221 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
693 |
446 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
422 |
376 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
387 |
248 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
69 |
68 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$523.11 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$213.47 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
125 |
108 |
$191.26 |